1. Home
  2. ARI vs NRIX Comparison

ARI vs NRIX Comparison

Compare ARI & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Apollo Commercial Real Estate Finance Inc

ARI

Apollo Commercial Real Estate Finance Inc

HOLD

Current Price

$10.13

Market Cap

1.5B

Sector

Real Estate

ML Signal

HOLD

Logo Nurix Therapeutics Inc. Common stock

NRIX

Nurix Therapeutics Inc. Common stock

HOLD

Current Price

$18.20

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARI
NRIX
Founded
2009
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2009
2020

Fundamental Metrics

Financial Performance
Metric
ARI
NRIX
Price
$10.13
$18.20
Analyst Decision
Buy
Strong Buy
Analyst Count
4
14
Target Price
$10.83
$26.50
AVG Volume (30 Days)
828.7K
1.6M
Earning Date
10-30-2025
01-27-2026
Dividend Yield
9.85%
N/A
EPS Growth
N/A
N/A
EPS
0.89
N/A
Revenue
$269,296,000.00
$83,687,000.00
Revenue This Year
$25.91
$58.38
Revenue Next Year
$14.63
N/A
P/E Ratio
$11.44
N/A
Revenue Growth
67.16
48.32
52 Week Low
$7.70
$8.18
52 Week High
$11.11
$22.95

Technical Indicators

Market Signals
Indicator
ARI
NRIX
Relative Strength Index (RSI) 54.46 74.70
Support Level $10.02 $16.02
Resistance Level $10.18 $17.79
Average True Range (ATR) 0.15 1.09
MACD 0.03 0.16
Stochastic Oscillator 64.42 96.31

Price Performance

Historical Comparison
ARI
NRIX

About ARI Apollo Commercial Real Estate Finance Inc

Apollo Commercial Real Estate Finance Inc is a real estate investment trust that primarily originates, invests in, acquires, and manages commercial first-mortgage loans, subordinate financings, commercial mortgage-backed securities, and other real estate-related debt investments. The subordinate loans and first-mortgage loans account for the vast majority of the portfolio on a cost basis. Property types include residential, retail, healthcare, office, mixed-use, hotel, industrial, multifamily, securities, and other, with residential properties and hotels representing the highest property value. More than a third of the properties are located in New York City, with the other properties located across other regions of the United States, as well as other countries.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: